Table 4 Neurodevelopmental outcomes in the preterm and term groups
|  | Preterm group (n = 114) | Term group (n = 104) | P value |
|---|---|---|---|
Follow-up age | 4.0 ± 1.5 | 4.4 ± 1.5 | 0.071 |
NDI | 92 (80.7%) | 89 (85.6%) | 0.338 |
CP | 86 (75.4%) | 64 (61.5%) | 0.027* |
GFMCS | |||
 I—III | 41 (36.0%) | 38 (36.5%) | 0.156 |
 IV—V | 45 (39.5%) | 26 (25.0%) |  |
ID (GQ < 70) | 41 (36.0%) | 59 (56.7%) | 0.002** |
EP | 21 (18.4%) | 51 (49.0%) |  < 0.001*** |
 West syndrome | 14 (12.3%) | 29 (27.9%) |  |
 Partial seizures | 3 (2.6%) | 11 (10.6%) |  |
 Generalized seizures | 4 (3.5%) | 9 (8.7%) |  |
 Mixed seizures | 0 | 2 (1.9%) |  |
Vision problem | 13 (11.4%) | 10 (9.6%) | 0.668 |
 Strabismus | 9 (7.9%) | 6 (5.8%) |  |
 Amblyopia | 4 (3.5%) | 1 (0.9%) |  |
 Blindness | 0 | 3 (2.9%) |  |
Deafness | 1 (0.9%) | / | / |